Tangential Flow Filtration Industry - Regional Synopsis
North American Market Forecast
The tangential flow filtration market in North America is projected to be the largest with a share of about 35% by the end of 2037. The growth of the market can be attributed majorly to the increasing growing investment in R&D in the biopharmaceutical sector as well as growing advancements in the field of biotechnology along with rising employment of tangential flow filtration methods for the separation and purification of biomolecules in the area of biological fields. For instance, it was found that the biopharmaceutical industry in the U.S. invested around USD 102 billion into R&D in 2018.
APAC Market Statistics
The Asia Pacific tangential flow filtration market is estimated to be the second largest, registering a share of about 30% by the end of 2037. The growth of the market can be attributed majorly to the growing existence of giant pharmaceutical manufacturers as well as increasing R&D in the field of biopharmaceuticals along with the rising inventions as well as innovations in the field of biologics and vaccines. The increase of CMOs in developing nations like China, Japan, and South Korea is another driving factor that leads to the market growth, as is the rising demand for biologics and pharmaceuticals, a sizable infusion of capital from domestic and foreign businesses, and these factors together. The desire for low-cost therapies, the modernization of medical procedures, and these factors will all contribute to the expansion of the TFF market in the region. Moreover, the uptrend installations of smaller bioreactors and multiproduct manufacturing facilities that have increased the demand for plug-and-play single-use TFF devices are also expected to boost the market growth in the region.
Europe Market Forecast
Further, the tangential flow filtration market in Europe is projected to hold a majority of the share by the end of 2037. The increasing level of funding and investment by the government as well as the widening scope of biopharmaceuticals with the development of novel biological products are factors attributed to the growth of the market in the European region in the upcoming years.
